
Published On: Nov 2022
Published On: Nov 2022
At 17.1% CAGR, the Asia Pacific Neurosurgical Robotics Market is projected to be worth US$ 1,127.73 Million by 2028, says Business Market Insights
According to Business Market Insights’ research, the Asia Pacific neurosurgical robotics market was valued at US$ 438.08 million in 2022 and is expected to reach US$ 1,127.73 million by 2028, registering an annual growth rate of 17.1% from 2022 to 2028. Rising number of product developments and approvals including rising nanorobots technology are the critical factors attributed to the market expansion.
The neurosurgical robotics market has the presence of many small and big companies. New component launch, regional expansion, product approval, and technological advancement are among the strategies adopted by companies to enlarge their market shares. Neurosurgical robots have become safer and more effective than ever with continuous innovations and technological advancements, boosting their acceptance among the masses. The active participation of market players in development activities, followed by increased product approvals by regulatory bodies, would offer lucrative opportunities for the growth of the neurosurgical robotics market in the coming years.
On the contrary, high installation costs of neurosurgical robotics hurdles the growth of Asia Pacific neurosurgical robotics market.
The Asia Pacific neurosurgical robotics market, based on application, is segmented into spinal and cranial. Spinal application is further segmented into spinal fusion, laminectomy, disc replacement, discectomy, foraminotomy, and others. The cranial segment is also subsegmented into brain biopsy, thermal ablation of seizure, surgical treatment of movement disorders, and others. In 2022, the spinal segment is anticipated to hold the largest share of the market, with a share of 63.0%, amassing US$ 275.96 million. It is projected to garner US$ 726.77 million by 2028 to expand at 17.5% CAGR during 2022–2028.
The Asia Pacific neurosurgical robotics market, based on surgery type, is segmented into open and minimally invasive. In 2022, the minimally invasive segment is anticipated to hold a larger share of the market in 2022 with a share of 84.1%, amassing US$ 368.42 million. It is projected to garner US$ 999.92 million by 2028 to expand at 18.1.% CAGR during 2022–2028.
Our regional analysis states that China captured 35.4% market share in 2022. It was assessed at US$ 155.23 million in 2022 and is likely to hit US$ 409.42 million by 2028, exhibiting a CAGR of 17.5% during the forecast period.
Key players dominating the Asia Pacific neurosurgical robotics market are Accuray Incorporated; B. Braun Melsungen AG; Brainlab AG; Brain Navi Biotechnology Co., Ltd.; Globus Medical, Inc.; Medtronic; Renishaw plc; NuVasive, Inc.; and Zimmer Biomet.
Below are listed a few recent key developments by major market players:
Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com